A case-control study on fat-to-muscle ratio and risk of breast cancer

Nutrition and Cancer

Volumn 61, Issue 4, 2009, Pages 466-474

  Ronco, Alvaro L ^a,b   Boeing, Heiner ^c   De Stefani, Eduardo ^d   Schulz, Mandy ^c   Schulze, Matthias ^c   Pischon, Tobias ^c  

^a Instituto Universitario CLAEH   (Uruguay)

^b Centro Hospitalario Pereira Rossell   (Uruguay)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST FEEDING; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; EDUCATIONAL STATUS; EXERCISE; FAMILY HISTORY; FEMALE; HUMAN; LIVE BIRTH; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; NULLIPARA; REPRODUCTION; RURAL AREA; SKELETAL MUSCLE; SKINFOLD; URBAN AREA; URUGUAY; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; MUSCLES; ODDS RATIO; QUESTIONNAIRES; URUGUAY; YOUNG ADULT;

PEREIRA;

EID: 70449638267     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580902725995     Document Type: Article

References (66)

1. World Cancer Research Fund: Food, Nutrition, and the Prevention of Cancer: A Global Perspective.Washington, DC:World Cancer Research Fund, 1987, pp. 252-287.
2. International Agency for Research on Cancer: Weight control and physical activity. IARC Handbooks of Cancer Prevention, Lyon, IARC Press. 2002, Vol.6.
3. Macinnis RJ, English DR, Gertig DM, Hopper JL, and Giles GG: Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13, 2117-2225, 2004.
4. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, et al.: Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111, 762-771, 2004. (Pubitemid 39062901)
5. Lahmann PH, Schulz M, Hoffmann K, Boeing H, Tjonneland A, et al.: Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer 93, 582-589, 2005. (Pubitemid 43080003)
6. Krebs EE, Taylor BC, Cauley JA, Stone KL, Bowman PJ, et al.: Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc 54, 63-69, 2006.
7. Mellemkjaer L, Bigaard J, Tjonneland A, Christensen J, Thomsen B, et al.: Body composition and breast cancer in postmenopausal women: a Danish prospective cohort study. Obesity (Silver Spring) 14, 1854-1862, 2006.
8. Shu XO, Jin F, Dai Q, Shi JR, Potter JD, et al.: Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 94, 449-455, 2001.
9. Chow LW, Lui KL, Chan JC, Chan TC, Ho PK, et al.: Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg 28, 179-184, 2005.
10. Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, et al.: Association of family history and other risk factors with breast cancer risk among Japanese premenopausal and postmenopausalwomen. Cancer Causes Control 12, 349-358, 2001.
11. Hall IJ, Newman B, Millikan RC, and Moorman PG: Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol 151, 754-764, 2000. (Pubitemid 30461139)
12. OkobiaMN, Bunker CH, Zmuda JM, Osime U, Ezeome ER, et al.: Anthropometry and breast cancer risk in Nigerian women. Breast J 12, 462-466, 2006.
13. Wu AH, Yu MC, Tseng CC, and Pike MC: Body size, hormone therapy and risk of breast cancer in Asian-American women. Int J Cancer 120, 844-852, 2007.
14. Wang Z, HeoM, Lee RC, Kotler DP,Withers RT, et al.:Muscularity in adult humans: proportion of adipose tissue-free body mass as skeletal muscle. Am J Hum Biol 13, 612-619, 2001.
15. Garbers S, Dubin N, Toniolo P, Wynder EL, and Taioli E: Comparison between hospitalized and screening controls in studies assessing breast cancer risk. Bull Cancer 91, E211-E224, 2004.
16. De Girolami DH: Fundamentals of Nutritional Assessment and Body Composition. Buenos Aires, Ed. El Ateneo, 2003. (In Spanish)
17. Ferńandez Vieitez JA: Anthropometric Estimates of Skeletal Muscle Mass in Human Beings. Available from www.siicsalud.com/des/ des042/05311002.htm. Accessed October 17, 2006. (In Spanish)
18. H́ebuterne X, Berman S, and Schneider SM: Aging and muscle: the effects of malnutrition, renutrition, and physical exercise. Curr Opin Clin Nutr Metab Care 4, 295-300, 2001.
19. Anderson GS: Humanmorphology and temperature regulating. Int J Biometeorol 43, 99-109, 1999.
20. Mariani E, Ravaglia G, Forti P, Meneghetti A, Tarozzi A, et al.: Vitamin D, thyroid hormones and muscle mass influence natural killer (NK) innate immunity in healthy nonagenarians and centenarians. Clin Exp Immunol 116, 19-27, 1999.
21. Marcell TJ: Sarcopenia: causes, consequences, and preventions. J Gerontol Med Sci 58A, 911-916, 2003.
22. Argiĺes JM, Ĺopez-Soriano J, Almendro V, Busquets S, and Ĺopez-Soriano F: Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med Res Rev 25, 49-65, 2005.
23. Fong Y, Moldawer LL, Morano M,Wei H, Barber A, et al.: Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 256, R659-R665,1989.
24. Meadows KA, Holly JM, and Stewart CE.: Tumor necrosis factor-alphainduced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J Cell Physiol 183, 330-337, 2000.
25. Carb́o N, Ribas V, Busquets S, Alvarez B, Ĺopez-Soriano F, et al: Shortterm effects of leptin on skeletal muscle protein metabolism in the rat. J Nutr Biochem 11, 431-435, 2000.
26. Pedersen BK, Akerström TC, Nielsen AR, and Fischer CP: Role of myokines in exercise and metabolism. J Appl Physiol 103, 1093-1098, 2007.
27. Heber D, Ingles S, Ashley JM, Maxwell MH, Lyons RF, et al.: Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am J Clin Nutr 64(3 Suppl), 472S-477S, 1996.
28. Parkin DM, Whelan SL, Ferlay J, Teppo L, and Thomas DB: Cancer incidence in five continents. IARC Sci Publ 155, Lyon, France: Int Agency Res Cancer, 2002, Vol.VIII.
29. De St́efani E, Ronco AL, Mendilaharsu M, Guidobono M, and Deneo- Pellegrini H: Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 6, 573-581, 1997. (Pubitemid 27342679)
30. De St́efani E, Correa P, Ronco AL, Mendilaharsu M, Guidobono M, et al.: Dietary fiber and risk of breast cancer. A case-control study in Uruguay. Nutr Cancer 28, 14-19, 1997. (Pubitemid 27287623)
31. De St́efani E, Deneo-Pellegrini H, Mendilaharsu M, and Ronco AL: Essential fatty acids and breast cancer: a case-control study in Uruguay. Int J Cancer 76, 491-494, 1998. (Pubitemid 28227990)
32. Ronco AL, De St́efani E, Mendilaharsu M, and Deneo-Pellegrini H: Meat, fat and the risk of breast cancer: a case-control study from Uruguay. Int J Cancer 65, 328-331, 1996. (Pubitemid 26059140)
33. Ronco AL, De St́efani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, et al.: Vegetables, fruits, and related nutrients and risk of breast cancer: a case control study in Uruguay. Nutr Cancer 35, 111-119, 1999.
34. Ronco AL, De St́efani E, and D́attoli R: Dairy foods and risk of breast cancer: a case-control study in Montevideo, Uruguay. Eur J Cancer Prev 11, 457-463, 2002.
35. Ronco AL, De St́efani E, and Fabra A: White meat intake and the risk of breast cancer: a case-control study in Montevideo, Uruguay. Nutr Res 23, 151-162, 2003.
36. Ronco AL, De St́efani E, Boffetta P, Deneo-Pellegrini H, Acosta G, et al.: Food patterns and risk of breast cancer: a factor analysis study in Uruguay. Int J Cancer 119, 1672-1678, 2006.
37. McTiernan A: Associations between energy balance and body mass index and risk of breast carcinoma in women from diverse racial and ethnic backgrounds in the U.S. Cancer 88, 1248-1255, 2000.
38. Friedenreich CM: Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10, 15-32, 2001.
39. Varas X, Leborgne F, and Leborgne JH: Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology 184, 1409-1414, 1992.
40. Feig SA: Role and evaluation ofmammography and other imagingmethods for breast cancer detection, diagnosis, and staging. Semin Nucl Med 29, 3-15, 1999.
41. Carter JEL: The Heath-Carter Anthropometric Somatotype-Instruction Manual. Surrey, British Columbia, Canada: TeP and Rosscraft, 2002.
42. Faulkner J: Physiology of swimming and diving. In Falls H: Exercise Physiology. Baltimore, MD: Academic Press, 1968.
43. De Rose EH, Pigatto E, and Celi R: Kinanthropometry, physical education and sport training. SEED, Brasilia, 1984. (In Portuguese)
44. Jackson AS and Pollack ML: Practical Assessment of body composition. Physician Sport Med 13, 76-90, 1985.
45. Heymsfield SB, Wang Z, Baumgartner RN, and Ross R: Human body composition: advances in models and methods. Ann Rev Nutr 17, 527-558, 1997.
46. Lee RC,Wang Z, HeoM, Ross R, Janssen I, et al.: Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr 72, 796-803, 2000.
47. Ferńandez Vieitez JA: Indexes of weight-height relationship as muscle mass indicators in adult women. Rev Cubana Aliment Nutr 16, 114-118, 2002. (In Spanish)
48. Breslow NE and Day NE: Statistical methods in cancer research: Volume 1. The analysis of case-control studies. IARC Sci Pub 32, Lyon, France: IARC, 1980.
49. Evans WJ and Campbell W: Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 123, 465-468, 1993.
50. Lanza-Jacoby S and Kaplan ML: Alterations in skeletal muscle proteins in obese and nonobese rats. Int J Obes 8, 451-456, 1984.
51. McPherron AC and Lee SJ: Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109, 595-601, 2002.
52. Sutrave P and Hughes SH: The ski oncogene. Oncogene 109, 353-356, 1991.
53. Costelli P, Carb́o N,Busquets S, Ĺopez-Soriano F,Baccino F, et al.:Reduced protein degradation rates and low expression of proteolytic systems support skeletal muscle hypertrophy in transgenic mice overexpressing the c-ski oncogene. Cancer Lett 200, 153-160, 2003.
54. Pedersen BK and Fischer CP: Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care 10, 265-271, 2007.
55. Pedersen BK: IL-6 signalling in exercise and disease. Biochem Soc Trans 35(Pt 5), 1295-1297, 2007.
56. Quinn LS, Andreson BG, Drivdahl RH, Alvarez B, and Argiĺes JM: Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: Implications for treatment of muscle wasting disorders. Exp Cell Res 280, 55-63, 2002.
57. Burton JD, Bamford RN, Peters C,Grant AJ,Kurys G, et al.:Alymphokine, provisionally designated interleukin T and produced by a human adult T cell leukemia line, stimulates T cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91, 4935-4939, 1994. (Pubitemid 24177765)
58. Carson WE, Giri JG, Lindemann MJ, Linett M, Ahdieh M, et al.: Interleukin (IL)15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180, 1395-1403, 1994.
59. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, et al.: IL-2 receptor common gamma-chain signaling cytokines regulate activated T-cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not proapoptotic (bax, bcl-xS) gene expression. Eur J Immunol 26, 294-299, 1996.
60. Girard D, Paquet ME, Paquin R, and Beaulieu AD.: Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: Modulation of phagocytosis, cytoskeleton rearrangement, gene expression and apoptosis by IL-15. Blood 88, 3176-3184, 1996.
61. AlvarezB,Carb́oN, Ĺopez-Soriano J,Drivdahl R, Busquets S, et al.: Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: Evidence for direct IL-15 action on adipose tissue. Biochim Biophys Acta 1570, 33-37, 2002.
62. Souba WW, Klimberg VS, Hautamaki RD, Mendenhall WH, Bova FC, et al.: Oral glutamine reduces bacterial translocation following abdominal radiation. J Surg Res 48, 1-5, 1990.
63. Kuhn KS, Schuhmann K, Stehle P, Darmaun D, and Furst P: Determination of glutamine inmuscle protein facilitates accurate assessment of proteolysis and de novo synthesis-derived endogenous glutamine production. Am J Clin Nutr 70, 484-489, 1999.
64. DarmaunD,MatthewsDE, and Bier DM:Glutamine and glutamate kinetics in humans. Am J Physiol 251, E117-E126, 1986.
65. Newsholme P: Why Is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 131, 2515S-2522S, 2001.
66. Crawford J and Cohen HJ: The essential role of glutamine in lymphocyte differentiation in vitro. J Cell Physiol 124, 275-282, 1995.